James Stillman Hanson

2018

In 2018, James Stillman Hanson earned a total compensation of $4.9M as General Counsel at G1 Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$71,094
Option Awards$4,654,469
Salary$169,271
Other$3,750
Total$4,898,584

Hanson received $4.7M in option awards, accounting for 95% of the total pay in 2018.

Hanson also received $71.1K in non-equity incentive plan, $169.3K in salary and $3.8K in other compensation.

Rankings

In 2018, James Stillman Hanson's compensation ranked 2,071st out of 14,244 executives tracked by ExecPay. In other words, Hanson earned more than 85.5% of executives.

ClassificationRankingPercentile
All
2,071
out of 14,244
86th
Division
Manufacturing
747
out of 5,765
87th
Major group
Chemicals And Allied Products
248
out of 2,128
88th
Industry group
Drugs
198
out of 1,817
89th
Industry
Pharmaceutical Preparations
152
out of 1,391
89th
Source: SEC filing on April 30, 2019.

Hanson's colleagues

We found five more compensation records of executives who worked with James Stillman Hanson at G1 Therapeutics in 2018.

2018

John Demaree

G1 Therapeutics

Chief Commercial Officer

2018

Terry Murdock

G1 Therapeutics

Chief Operating Officer

2018

Mark Velleca

G1 Therapeutics

Chief Executive Officer

2018

Rajesh Malik

G1 Therapeutics

Chief Medical Officer

2018

Barclay Phillips

G1 Therapeutics

Chief Financial Officer

News

In-depth

You may also like